Meghmani Organics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 19, 2025, 9:55 pm

Competitors of Meghmani Organics Ltd

All Competitor Stocks of Meghmani Organics Ltd

Quarterly Result

Last Updated: August 1, 2025, 5:05 pm

Below is a detailed analysis of the quarterly data for Meghmani Organics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 614.00 Cr.. The value appears strong and on an upward trend. It has increased from 553.00 Cr. (Mar 2025) to 614.00 Cr., marking an increase of 61.00 Cr..
• For Expenses, as of Jun 2025, the value is 547.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 488.00 Cr. (Mar 2025) to 547.00 Cr., marking an increase of 59.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 65.00 Cr. (Mar 2025) to 67.00 Cr., marking an increase of 2.00 Cr..
• For OPM %, as of Jun 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Mar 2025) to 11.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 10.00 Cr..
• For Depreciation, as of Jun 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Mar 2025) to 30.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 7.00 Cr..
• For Tax %, as of Jun 2025, the value is 48.00%. The value appears to be increasing, which may not be favorable. It has increased from 35.00% (Mar 2025) to 48.00%, marking an increase of 13.00%.
• For Net Profit, as of Jun 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Mar 2025) to 13.00 Cr., marking a decrease of 7.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.50. The value appears to be declining and may need further review. It has decreased from 0.78 (Mar 2025) to 0.50, marking a decrease of 0.28.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:52 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: November 9, 2025, 2:30 pm

Below is a detailed analysis of the balance sheet data for Meghmani Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,514.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,490.00 Cr. (Mar 2025) to 1,514.00 Cr., marking an increase of 24.00 Cr..
• For Borrowings, as of Sep 2025, the value is 841.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 829.00 Cr. (Mar 2025) to 841.00 Cr., marking an increase of 12.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 905.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 741.00 Cr. (Mar 2025) to 905.00 Cr., marking an increase of 164.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 3,285.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,085.00 Cr. (Mar 2025) to 3,285.00 Cr., marking an increase of 200.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 1,540.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,575.00 Cr. (Mar 2025) to 1,540.00 Cr., marking a decrease of 35.00 Cr..
• For CWIP, as of Sep 2025, the value is 80.00 Cr.. The value appears to be declining and may need further review. It has decreased from 83.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 3.00 Cr..
• For Investments, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,662.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,425.00 Cr. (Mar 2025) to 1,662.00 Cr., marking an increase of 237.00 Cr..
• For Total Assets, as of Sep 2025, the value is 3,285.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,085.00 Cr. (Mar 2025) to 3,285.00 Cr., marking an increase of 200.00 Cr..

Notably, the Reserves (1,514.00 Cr.) exceed the Borrowings (841.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Meghmani Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -0.42. This value is below the healthy minimum of 5. It has increased from -4.17 (Mar 24) to -0.42, marking an increase of 3.75.
• For Diluted EPS (Rs.), as of Mar 25, the value is -0.42. This value is below the healthy minimum of 5. It has increased from -4.17 (Mar 24) to -0.42, marking an increase of 3.75.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.83. This value is within the healthy range. It has increased from -0.54 (Mar 24) to 3.83, marking an increase of 4.37.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 59.58. It has decreased from 60.07 (Mar 24) to 59.58, marking a decrease of 0.49.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 59.58. It has decreased from 60.07 (Mar 24) to 59.58, marking a decrease of 0.49.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 81.78. It has increased from 61.59 (Mar 24) to 81.78, marking an increase of 20.19.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 7.34. This value is within the healthy range. It has increased from 0.68 (Mar 24) to 7.34, marking an increase of 6.66.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.09. This value is within the healthy range. It has increased from -2.94 (Mar 24) to 3.09, marking an increase of 6.03.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from -4.76 (Mar 24) to 0.37, marking an increase of 5.13.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 2. It has increased from -4.17 (Mar 24) to -0.41, marking an increase of 3.76.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 2. It has increased from -4.17 (Mar 24) to -0.41, marking an increase of 3.76.
• For PBDIT Margin (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 10. It has increased from 1.11 (Mar 24) to 8.97, marking an increase of 7.86.
• For PBIT Margin (%), as of Mar 25, the value is 3.77. This value is below the healthy minimum of 10. It has increased from -4.77 (Mar 24) to 3.77, marking an increase of 8.54.
• For PBT Margin (%), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 10. It has increased from -7.73 (Mar 24) to 0.45, marking an increase of 8.18.
• For Net Profit Margin (%), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 5. It has increased from -6.76 (Mar 24) to -0.50, marking an increase of 6.26.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 8. It has increased from -6.76 (Mar 24) to -0.50, marking an increase of 6.26.
• For Return on Networth / Equity (%), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 15. It has increased from -6.94 (Mar 24) to -0.69, marking an increase of 6.25.
• For Return on Capital Employeed (%), as of Mar 25, the value is 4.17. This value is below the healthy minimum of 10. It has increased from -3.77 (Mar 24) to 4.17, marking an increase of 7.94.
• For Return On Assets (%), as of Mar 25, the value is -0.34. This value is below the healthy minimum of 5. It has increased from -3.48 (Mar 24) to -0.34, marking an increase of 3.14.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 0.2. It has decreased from 0.25 (Mar 24) to 0.18, marking a decrease of 0.07.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.54.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.67. It has increased from 0.50 (Mar 24) to 0.67, marking an increase of 0.17.
• For Current Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 1.5. It has decreased from 1.15 (Mar 24) to 1.12, marking a decrease of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.65 (Mar 24) to 0.62, marking a decrease of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.30. This value is below the healthy minimum of 4. It has increased from 1.55 (Mar 24) to 2.30, marking an increase of 0.75.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -33.58 (Mar 24) to 0.00, marking an increase of 33.58.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -257.96 (Mar 24) to 0.00, marking an increase of 257.96.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 133.58 (Mar 24) to 0.00, marking a decrease of 133.58.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 357.96 (Mar 24) to 0.00, marking a decrease of 357.96.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.70. This value is below the healthy minimum of 3. It has increased from 0.37 (Mar 24) to 2.70, marking an increase of 2.33.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 3. It has increased from -1.29 (Mar 24) to 0.84, marking an increase of 2.13.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,357.58. It has decreased from 2,831.39 (Mar 24) to 2,357.58, marking a decrease of 473.81.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.13. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.13, marking a decrease of 0.68.
• For EV / EBITDA (X), as of Mar 25, the value is 12.63. This value is within the healthy range. It has decreased from 162.66 (Mar 24) to 12.63, marking a decrease of 150.03.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.29 (Mar 24) to 0.74, marking a decrease of 0.55.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 133.58 (Mar 24) to 0.00, marking a decrease of 133.58.
• For Price / BV (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has decreased from 1.32 (Mar 24) to 1.03, marking a decrease of 0.29.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.29 (Mar 24) to 0.74, marking a decrease of 0.55.
• For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has increased from -0.05 (Mar 24) to -0.01, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness